IFNA2 and infection: Next, we analyzed whether type I IFNs show any antiviral activity against HCoV-229E by pretreating A549 cells with different doses of IFN-α (1 or 10 ng/mL, 24 h) followed by an infection with HCoV-229E for 24 hours (MOI 10–0.04).